---
figid: PMC9610969__medicina-58-01377-g002
figtitle: 'Molecular Pathways Related to Sulforaphane as Adjuvant Treatment: A Nanomedicine
  Perspective in Breast Cancer'
organisms:
- Arabidopsis thaliana
- Brassica napus
- Brassica oleracea
- Raphanus sativus
- Brassica rapa subsp. pekinensis
- Brassica rapa subsp. rapa
- Nasturtium officinale
- Brassica rapa subsp. chinensis
- Brassica oleracea var. italica
- Brassica napus subsp. rapifera
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Lactiplantibacillus pentosus
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Drosophila melanogaster
pmcid: PMC9610969
filename: medicina-58-01377-g002.jpg
figlink: /pmc/articles/PMC9610969/figure/medicina-58-01377-f002/
number: F2
caption: Reported anti-tumour mechanisms of sulforaphane as adjuvant. Mechanisms reported
  for liposome nanoparticles microemulsion, methoxy poly (ethylene glycol)-poly (lactide-co-glycolide)
  and poly (D, L-lactideco-glycolide)/hyaluronic acid nanoparticles loaded with sulforaphane
  and chemotherapeutic agents such as DOX, PTX, cisplatin, and DTX. Among the biological
  mechanisms of these nanoparticles are the activation of apoptosis through the mitochondrial
  pathway, autophagy, and the decrease in the viability of cancer steam cells.
papertitle: 'Molecular Pathways Related to Sulforaphane as Adjuvant Treatment: A Nanomedicine
  Perspective in Breast Cancer.'
reftext: Mar√≠a Zenaida Saavedra-Leos, et al. Medicina (Kaunas). 2022 Oct;58(10):1377.
year: '2022'
doi: 10.3390/medicina58101377
journal_title: Medicina
journal_nlm_ta: Medicina (Kaunas)
publisher_name: MDPI
keywords: breast cancer | sulforaphane | nanomolecule
automl_pathway: 0.7185991
figid_alias: PMC9610969__F2
figtype: Figure
redirect_from: /figures/PMC9610969__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9610969__medicina-58-01377-g002.html
  '@type': Dataset
  description: Reported anti-tumour mechanisms of sulforaphane as adjuvant. Mechanisms
    reported for liposome nanoparticles microemulsion, methoxy poly (ethylene glycol)-poly
    (lactide-co-glycolide) and poly (D, L-lactideco-glycolide)/hyaluronic acid nanoparticles
    loaded with sulforaphane and chemotherapeutic agents such as DOX, PTX, cisplatin,
    and DTX. Among the biological mechanisms of these nanoparticles are the activation
    of apoptosis through the mitochondrial pathway, autophagy, and the decrease in
    the viability of cancer steam cells.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Trp53
  - Bax
  - Nkx3-1
  - Casp3
  - Casp9
  - Bcl2
  - Parp1
  - Ctnnb1
  - Ccnd1
  - TP53
  - TP63
  - TP73
  - BAX
  - BCL2
  - PARP1
  - COL11A2
  - PARP2
  - PARP3
  - PARP4
  - PARP6
  - PARP8
  - PARP9
  - PARP10
  - PARP11
  - PARP12
  - PARP14
  - PARP15
  - PARP16
  - TNKS
  - TNKS2
  - TIPARP
  - CTNNB1
  - CCND1
  - Tp53
  - p53
  - betaTub60D
  - hth
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - poly
  - Decay
  - Dronc
  - Debcl
  - Parp
  - arm
---
